Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,364 INR | -0.53% | +1.03% | +19.26% |
Sales 2024 * | 103B 1.24B | Sales 2025 * | 117B 1.4B | Capitalization | 947B 11.34B |
---|---|---|---|---|---|
Net income 2024 * | 18.3B 219M | Net income 2025 * | 21.75B 261M | EV / Sales 2024 * | 8.94 x |
Net cash position 2024 * | 25.25B 302M | Net cash position 2025 * | 43.42B 520M | EV / Sales 2025 * | 7.75 x |
P/E ratio 2024 * |
51.7
x | P/E ratio 2025 * |
43.4
x | Employees | 18,468 |
Yield 2024 * |
0.29% | Yield 2025 * |
0.41% | Free-Float | 19.91% |
Latest transcript on Mankind Pharma Limited
1 day | -0.53% | ||
1 week | +1.03% | ||
Current month | +2.77% | ||
1 month | +2.77% | ||
3 months | +13.05% | ||
6 months | +34.43% | ||
Current year | +19.26% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 2,364 | -0.53% | 231,691 |
24-04-29 | 2,377 | +0.34% | 209,100 |
24-04-26 | 2,369 | -1.23% | 197,510 |
24-04-25 | 2,399 | +0.01% | 186,814 |
24-04-24 | 2,398 | +0.22% | 569,613 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.26% | 11.35B | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- MANKIND Stock